160 related articles for article (PubMed ID: 29685377)
1. Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer.
Fang P; Musall BC; Son JB; Moreno AC; Hobbs BP; Carter BW; Fellman BM; Mawlawi O; Ma J; Lin SH
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):996-1001. PubMed ID: 29685377
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Cancer Using
Borggreve AS; Goense L; van Rossum PSN; Heethuis SE; van Hillegersberg R; Lagendijk JJW; Lam MGEH; van Lier ALHMW; Mook S; Ruurda JP; van Vulpen M; Voncken FEM; Aleman BMP; Bartels-Rutten A; Ma J; Fang P; Musall BC; Lin SH; Meijer GJ
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):998-1009. PubMed ID: 31987972
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of
Valkema MJ; Noordman BJ; Wijnhoven BPL; Spaander MCW; Biermann K; Lagarde SM; Bennink RJ; Schreurs WMJ; Roef MJ; Hobbelink MGG; Janssen MJR; Graven LH; van Lanschot JJB; Valkema R
J Nucl Med; 2019 Nov; 60(11):1553-1559. PubMed ID: 30877177
[TBL] [Abstract][Full Text] [Related]
5. Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.
Borggreve AS; Heethuis SE; Boekhoff MR; Goense L; van Rossum PSN; Brosens LAA; van Lier ALHMW; van Hillegersberg R; Lagendijk JJW; Mook S; Ruurda JP; Meijer GJ
Eur Radiol; 2020 Apr; 30(4):1896-1907. PubMed ID: 31822974
[TBL] [Abstract][Full Text] [Related]
6. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.
Elimova E; Wang X; Etchebehere E; Shiozaki H; Shimodaira Y; Wadhwa R; Planjery V; Charalampakis N; Blum MA; Hofstetter W; Lee JH; Weston BR; Bhutani MS; Rogers JE; Maru D; Skinner HD; Macapinlac HA; Ajani JA
Eur J Cancer; 2015 Nov; 51(17):2545-52. PubMed ID: 26321501
[TBL] [Abstract][Full Text] [Related]
7. Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.
Stiekema J; Vermeulen D; Vegt E; Voncken FE; Aleman BM; Sanders J; Boot H; van Sandick JW
Clin Nucl Med; 2014 Oct; 39(10):862-7. PubMed ID: 25140549
[TBL] [Abstract][Full Text] [Related]
8.
Avallone A; Aloj L; Pecori B; Caracò C; De Stefano A; Tatangelo F; Silvestro L; Granata V; Bianco F; Romano C; Di Gennaro F; Budillon A; Petrillo A; Muto P; Botti G; Delrio P; Lastoria S
J Nucl Med; 2019 Nov; 60(11):1560-1568. PubMed ID: 30877175
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of mid-radiotherapy
Kim N; Cho H; Yun M; Park KR; Lee CG
Radiat Oncol; 2019 Feb; 14(1):27. PubMed ID: 30717809
[TBL] [Abstract][Full Text] [Related]
10. Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
Tan S; Kligerman S; Chen W; Lu M; Kim G; Feigenberg S; D'Souza WD; Suntharalingam M; Lu W
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1375-82. PubMed ID: 23219566
[TBL] [Abstract][Full Text] [Related]
11. 3'-deoxy-3'-[¹⁸F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer: comparison with [¹⁸F]-FDG PET/CT.
Chen H; Li Y; Wu H; Sun L; Lin Q; Zhao L; An H
Strahlenther Onkol; 2015 Feb; 191(2):141-52. PubMed ID: 25163419
[TBL] [Abstract][Full Text] [Related]
12. The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease.
Barbaro B; Leccisotti L; Vecchio FM; Di Matteo M; Serra T; Salsano M; Poscia A; Coco C; Persiani R; Alfieri S; Gambacorta MA; Valentini V; Giordano A; Bonomo L
Br J Radiol; 2017 Jan; 90(1069):20150836. PubMed ID: 27845566
[TBL] [Abstract][Full Text] [Related]
13. Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
Zhang H; Tan S; Chen W; Kligerman S; Kim G; D'Souza WD; Suntharalingam M; Lu W
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):195-203. PubMed ID: 24189128
[TBL] [Abstract][Full Text] [Related]
14. Texture analysis of
Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
[TBL] [Abstract][Full Text] [Related]
15. Role of multi-modality functional imaging in differentiation between benign and malignant thyroid
Shi H; Yuan Z; Yang C; Zhang J; Liu C; Sun J; Ye X
Clin Transl Oncol; 2019 Nov; 21(11):1561-1567. PubMed ID: 30924093
[TBL] [Abstract][Full Text] [Related]
16. Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer.
Wong KH; Panek R; Dunlop A; Mcquaid D; Riddell A; Welsh LC; Murray I; Koh DM; Leach MO; Bhide SA; Nutting CM; Oyen WJ; Harrington KJ; Newbold KL
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):759-767. PubMed ID: 29164301
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients.
Li YM; Lin Q; Zhao L; Wang LC; Sun L; Dai MM; Luo ZM; Zheng H; Wu H
Asian Pac J Cancer Prev; 2014; 15(3):1369-73. PubMed ID: 24606467
[TBL] [Abstract][Full Text] [Related]
18. Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.
Harada K; Wu CC; Wang X; Mizrak Kaya D; Amlashi FG; Iwatsuki M; Blum Murphy MA; Maru DM; Weston B; Lee JH; Rogers JE; Thomas I; Shanbhag N; Bhutani MS; Hofstetter WL; Nguyen QN; Ajani JA
Ann Surg; 2020 Aug; 272(2):311-318. PubMed ID: 32675544
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of
Yu CW; Chen XJ; Lin YH; Tseng YH; Lu CC; Chen BB; Wei SY; Lee JM; Shih TT
Eur J Radiol; 2019 Nov; 120():108671. PubMed ID: 31629121
[TBL] [Abstract][Full Text] [Related]
20. Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
Gerbaudo VH; Killoran JH; Kim CK; Hornick JL; Nowak JA; Enzinger PC; Mamon HJ
Ann Nucl Med; 2018 Apr; 32(3):165-174. PubMed ID: 29332233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]